Suppr超能文献

腹横肌平面阻滞治疗疝修补术后慢性疼痛的长期结局及预测因素

Long-Term Outcome and Predictors of Transversus Abdominis Plane Block for Chronic Post-Hernioplasty Pain.

作者信息

Freo Ulderico, Furnari Maurizio

机构信息

Institute of Anesthesia and Intensive Care, Department of Medicine-DIMED, Padua University Hospital, Via Giustiniani 2, 35121 Padua, Italy.

出版信息

J Clin Med. 2024 Jul 10;13(14):4039. doi: 10.3390/jcm13144039.

Abstract

: Different analgesic techniques have been used in the clinical management of chronic post-hernioplasty pain (CPHP), with variable results. This study aimed to investigate clinical factors associated with long-term outcome of the transversus abdominal plane (TAP) block for CPHP. : We retrospectively analyzed 26 patients with CPHP who were treated with single or multiple TAP blocks with local anesthetic and steroid. Patients were evaluated for pain and neuropathic pain intensity by a Numerical Rating Scale (NRS) and the painDETECT questionnaire (PDQ), for anxiety and depression by the Hospital Anxiety and Depression Scale, and for quality of life by the 12-item Short Form Health Survey (SF12). : At 6 months post-treatment, 20 patients (77%) presented substantial (>50%) or moderate (30-50%) CPHP relief and were considered responders. In responders, the 24-h average and maximum NRS pain significantly declined ( < 0.01) from 7.3 ± 1.3 to 2.6 ± 2.1 and from 8.8 ± 1.5 to 5.1 ± 2.0, and the neuropathic PDQ score from 9.1 ± 3.2 to 6.1 ± 1.3; the physical SF12 score improved from 36.5 ± 5.8 to 44.3 ± 7.5 ( < 0.01). Six patients failed to achieve a significant CPHP improvement and were considered non-responders. Non-responders presented a significantly ( < 0.05) longer CPHP, higher body mass index and neuropathic symptoms, and more frequent anxiety, depression, diabetes, and fibromyalgia. : The TAP block with local anesthetic and steroid should be considered as a therapeutic option for CPHP. However, medical and psychiatric comorbidities negatively impact the TAP block effectiveness for CPHP.

摘要

不同的镇痛技术已被用于慢性疝修补术后疼痛(CPHP)的临床管理,结果各异。本研究旨在调查与CPHP的腹横肌平面(TAP)阻滞长期疗效相关的临床因素。

我们回顾性分析了26例接受单次或多次局部麻醉药和类固醇TAP阻滞治疗的CPHP患者。通过数字评分量表(NRS)和疼痛检测问卷(PDQ)评估患者的疼痛和神经性疼痛强度,通过医院焦虑抑郁量表评估焦虑和抑郁情况,通过12项简短健康调查(SF12)评估生活质量。

治疗后6个月,20例患者(77%)CPHP得到显著(>50%)或中度(30 - 50%)缓解,被视为反应者。反应者的24小时平均和最大NRS疼痛评分从7.3±1.3显著降至2.6±2.1(P<0.01),从8.8±1.5降至5.1±2.0,神经性PDQ评分从9.1±3.2降至6.1±1.3;身体SF12评分从36.5±5.8提高到44.3±7.5(P<0.01)。6例患者CPHP未得到显著改善,被视为无反应者。无反应者的CPHP病程显著更长(P<0.05),体重指数和神经性症状更高,焦虑、抑郁、糖尿病和纤维肌痛更频繁。

局部麻醉药和类固醇的TAP阻滞应被视为CPHP的一种治疗选择。然而,内科和精神科合并症对CPHP的TAP阻滞有效性有负面影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eca/11278023/0efd3a58ac9b/jcm-13-04039-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验